Cited by 352T-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersImmune cells in cancer

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression

Xiao, Xiao, Lao, Xiang-Ming, Chen, Min-Min, Liu, Rui-Xian, Wei, Yuan, Ouyang, Fang-Zhu, Chen, Dong-Ping, Zhao, Xiao-Yu, Zhao, Qiyi, Li, Xue-Feng, Liu, Chuan-Lu, Zheng, Limin, Kuang, Dong-Ming·2016·Cancer Discovery

DOI 10.1158/2159-8290.cd-15-1408

Published version of a preprint

Open this paper in CoChat — free account

Abstract

UNLABELLED: B cells often constitute abundant cellular components in human tumors. Regulatory B cells that are functionally defined by their ability to produce IL10 downregulate inflammation and control T-cell immunity. Here, we identified a protumorigenic subset of B cells that constitutively expressed higher levels of programmed cell death-1 (PD-1) and constituted ∼10% of all B cells in advanced-stage hepatocellular carcinoma (HCC). These PD-1(hi) B cells exhibited a unique CD5(hi)CD24(-/+)CD27(hi/+)CD38(dim) phenotype different from the phenotype of conventional CD24(hi)CD38(hi) peripheral regulatory B cells. TLR4-mediated BCL6 upregulation was crucial for PD-1(hi) B-cell induction by HCC environmental factors, and that effect was abolished by IL4-elicited STAT6 phosphorylation. Importantly, upon encountering PD-L1(+) cells or undergoing PD-1 triggering, PD-1(hi) B cells acquired regulatory functions that suppressed tumor-specific T-cell immunity and promoted cancer growth via IL10 signals. Our findings provide significant new insights for human cancer immunosuppression and anticancer therapies regarding PD-1/PD-L1. SIGNIFICANCE: We identify a novel protumorigenic PD-1(hi) B-cell subset in human HCC that exhibits a phenotype distinct from that of peripheral regulatory B cells. TLR4-mediated BCL6 upregulation is critical for induction of PD-1(hi) B cells, which operate via IL10-dependent pathways upon interacting with PD-L1 to cause T-cell dysfunction and foster disease progression. Cancer Discov; 6(5); 546-59. ©2016 AACR.See related commentary by Ren et al., p. 477This article is highlighted in the In This Issue feature, p. 461.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-15-1408

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Follicular Helper CD4 T Cells (T FH )
Crotty, S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101400 · Cited by 2,738
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H. L., Burnette, B., Beckett, M., Darga, T. E., Weichselbaum, R. R., & Fu, Y. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,119
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487
Innate Immune Pattern Recognition: A Cell Biological Perspective
Brubaker, S. W., Bonham, K. S., Zanoni, I., & Kagan, J. C. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112240 · Cited by 1,475
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314

Show all 46 references

Sorted by citations

Tertiary lymphoid structures in the era of cancer immunotherapy
Sautès-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0144-6 · Cited by 1,884
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
Seidel, J. A., Otsuka, A., & Kabashima, K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00086 · Cited by 1,360
Advances in immunotherapy for hepatocellular carcinoma
Sangro, B., Sarobe, P., Hervás-Stubbs, S., & Melero, I. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00438-0 · Cited by 1,306
Tumor-infiltrating lymphocytes in the immunotherapy era
Paijens, S. T., Vledder, A., de Bruyn, M., & Nijman, H. W. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00565-9 · Cited by 914
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Donné, R., & Lujambio, A. (2022) · Hepatology · doi:10.1002/hep.32740 · Cited by 659
B cell regulation in cancer and anti-tumor immunity
Sarvaria, A., Madrigal, J. A., & Saudemont, A. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.35 · Cited by 652
Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
Sanz, I., Wei, C., Jenks, S. A., Cashman, K. S., Tipton, C., Woodruff, M. C., Hom, J., & Lee, F. E.-H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02458 · Cited by 569
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P., & Nelson, B. H. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00466-1 · Cited by 565
Immunosuppressive Mechanisms of Regulatory B Cells
Catalán, D., Mansilla, M. A., Ferrier, A., Soto, L., Oļeiņika, K., Aguillón, J. C., & Aravena, O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.611795 · Cited by 429
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma
Ruffin, A. T., Cillo, A. R., Tabib, T., Liu, A., Onkar, S., Kunning, S. R., Lampenfeld, C., Atiya, H. I., Abécassis, I., Kürten, C. H. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23355-x · Cited by 377
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Zheng, J., Wang, S., Xia, L., Sun, Z., Chan, K. M., Bernards, R., Qin, W., Chen, J., Xia, Q., & Jin, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02075-w · Cited by 421
Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
Chen, C., Wang, Z., Ding, Y., & Qin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133308 · Cited by 336
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion
Ye, L., Zhang, Q., Cheng, Y., Chen, X., Wang, G., Shi, M., Zhang, T., Cao, Y., Hang, P., Zhang, L., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0451-6 · Cited by 306
B Cell Function in the Tumor Microenvironment
Downs‐Canner, S., Meier, J. A., Vincent, B. G., & Serody, J. S. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-015603 · Cited by 306
Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity
Lu, Y., Zhao, Q., Liao, J., Song, E., Xia, Q., Pan, J., Li, Y., Li, J., Zhou, B., Ye, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.015 · Cited by 281
Self-citation
A blueprint for tumor-infiltrating B cells across human cancers
Ma, J., Wu, Y. C., Ma, L., Yang, X., Zhang, T., Song, G., Li, T., Gao, K., Shen, X., Lin, J., et al. (2024) · Science · doi:10.1126/science.adj4857 · Cited by 284
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Laumont, C. M., & Nelson, B. H. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.017 · Cited by 269
PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
Li, Q., Han, J., Yang, Y., & Chen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1070961 · Cited by 255
Emerging immunotherapy for HCC: A guide for hepatologists
Foerster, F., Gairing, S. J., Ilyas, S. I., & Galle, P. R. (2022) · Hepatology · doi:10.1002/hep.32447 · Cited by 245
B cell regulation of the anti-tumor response and role in carcinogenesis
Schwartz, M. A., Zhang, Y. X., & Rosenblatt, J. D. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0145-x · Cited by 244
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
Giraud, J., Chalopin, D., Blanc, J., & Saleh, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.655697 · Cited by 226
Regulatory B cells in cancer
Michaud, D. E., Steward, C. R., Mirlekar, B., & Pylayeva‐Gupta, Y. (2020) · Immunological Reviews · doi:10.1111/imr.12939 · Cited by 211
Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling
Hu, Q., Hong, Y., Qi, P., Lu, G., Mai, X., Xu, S., He, X., Guo, Y., Gao, L., Jing, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22300-2 · Cited by 201
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
Hou, J., Zhang, H., Sun, B., & Karin, M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.014 · Cited by 198
Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
Wu, C., Ning, H., Liu, M., Lin, J., Luo, S., Zhu, W., Jing, X., Wu, W.-C., Liang, J., Shao, C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97973 · Cited by 200
Self-citation
The B-Side of Cancer Immunity: The Underrated Tune
Largeot, A., Pagano, G., Gonder, S., Moussay, E., & Paggetti, J. (2019) · Cells · doi:10.3390/cells8050449 · Cited by 189
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Giraldo, N. A., Nguyen, P. L., Engle, E. L., Kaunitz, G. J., Cottrell, T. R., Berry, S., Green, B., Soni, A., Cuda, J. D., Stein, J. E., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0404-0 · Cited by 175
Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
Bai, J., Gao, Z., Li, X., Dong, L., Han, W., & Nie, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22690 · Cited by 159
Self-citation
B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication
Kinker, G. S., Vitiello, G. A. F., Ferreira, W. A. S., Chaves, A. S., de Lima, V. C. C., & Medina, T. D. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.678127 · Cited by 154
Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Zheng, Y., Han, Y., Sun, Q., & Li, Z. (2022) · Exploration · doi:10.1002/exp.20210166 · Cited by 151
Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
Hao, X., Sun, G., Zhang, Y., Kong, X., Rong, D., Song, J., Tang, W., & Wang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775462 · Cited by 147
PD-1-expressing B cells suppress CD4+ and CD8+ T cells via PD-1/PD-L1-dependent pathway
Wang, X., Wang, G., Wang, Z., Liu, B., Han, N., Li, J., Lu, C., Liu, X., Zhang, Q., Yang, Q., et al. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.02.009 · Cited by 142
Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies
Jacquelot, N., Tellier, J., Nutt, S. L., & Belz, G. T. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1900508 · Cited by 144
Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma
Zhang, Z., Ma, L., Goswami, S., Ma, J., Zheng, B., Duan, M., Liu, L., Zhang, L., Shi, J.-Y., Dong, L., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1571388 · Cited by 137
The B7:CD28 family and friends: Unraveling coinhibitory interactions
Burke, K. P., Chaudhri, A., Freeman, G. J., & Sharpe, A. H. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.013 · Cited by 148
Innate immune mediators in cancer: between defense and resistance
Berraondo, P., Minute, L., Ajona, D., Corrales, L. P., Melero, I., & Pı́o, R. (2016) · Immunological Reviews · doi:10.1111/imr.12464 · Cited by 134
Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes
Lizotte, P. H., Ivanova, E. V., Awad, M. M., Jones, R. E., Keogh, L., Liu, H., Dries, R., Almonte, C. G., Herter-Sprie, G. S., Santos, A. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89014 · Cited by 123
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment
Lv, J., Yuan, W., Yin, J., Chen, Y., Zhou, G., Chen, W., Liang, X., Zhang, Y., Zhang, C., He, S., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02369-6 · Cited by 132
Self-citation
Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice
Yuan, W., Lao, X., Xiao, C., Wang, X., Wu, Z.-J., Zeng, Q., Wu, C.-Y., Wu, R., Chen, Z.-X., Zheng, L., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.250 · Cited by 120
Self-citation
HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape
Han, Q., Zhao, H., Yu, J., Yin, C., & Zhang, J. (2019) · Cells · doi:10.3390/cells8060558 · Cited by 120
Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma
Swamydas, M., Murphy, E. V., Ignatz-Hoover, J. J., Malek, E., & Driscoll, J. J. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01234-2 · Cited by 121
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy
Franken, A., Bila, M., Mechels, A., Kint, S., Dessel, J. V., Pomella, V., Vanuytven, S., Philips, G., Bricard, O., Xiong, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.007 · Cited by 128
The Role of Regulatory B Cells in Health and Diseases: A Systemic Review
Abebe, E. C., Dejenie, T. A., Ayele, T. M., Baye, N. D., Teshome, A. A., & Muche, Z. T. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s286426 · Cited by 117
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yin, Y., Feng, W., Chen, J., Chen, X., Wang, G., Wang, S., Xu, X., Nie, Y., Fan, D., Wu, K., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00539-x · Cited by 122
The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Yuan, W., Zhao, Q., Gao, Z., Lao, X., Lin, W., Chen, D., Mu, M., Huang, C.-X., Liu, Z., Li, B., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127726 · Cited by 114
Self-citation
Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13+CD103+CD8+ Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy
Hu, C., You, W., Kong, D., Huang, Y., Lu, J., Zhao, M., Jin, Y., Peng, R., Hua, D., Kuang, D., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.10.022 · Cited by 107
Self-citation
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication
Wang, H., Wang, T., Yan, S., Tang, J., Zhang, Y., Wang, L., Xu, H., & Tu, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02183-9 · Cited by 122
Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma
Ouyang, F., Wu, R., Yuan, W., Liu, R., Yang, D., Xiao, C., Zheng, L., Li, B., Lao, X., & Kuang, D. (2016) · Nature Communications · doi:10.1038/ncomms13453 · Cited by 102
Self-citation
A novel MDSC-induced PD-1 − PD-L1 + B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties
Shen, M., Wang, J., Yu, W., Zhang, C., Liu, M., Wang, K., Yang, L., Wei, F., Wang, S. E., Sun, Q., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1413520 · Cited by 104
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Hanahan, D., Michielin, O. A., & Pittet, M. J. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00761-z · Cited by 106
Trajectory and Functional Analysis of PD‐1 high CD4 + CD8 + T Cells in Hepatocellular Carcinoma by Single‐Cell Cytometry and Transcriptome Sequencing
Zheng, B. J., Wang, D., Qiu, X., Luo, G., Wu, T., Yang, S., Li, Z., Zhu, Y., Wang, S., Wu, R. T., et al. (2020) · Advanced Science · doi:10.1002/advs.202000224 · Cited by 100
The Role of Tumor-Infiltrating B Cells in Tumor Immunity
Guo, F. F., & Cui, J. W. (2019) · Journal of Oncology · doi:10.1155/2019/2592419 · Cited by 101
The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer
Chen, Y., Zheng, X., & Wu, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.792691 · Cited by 104
CD8 + T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapy
Huang, Y., Jia, A., Wang, Y., & Liu, G. (2022) · Immunology · doi:10.1111/imm.13588 · Cited by 96
Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer
Shang, J., Zha, H., & Sun, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582657 · Cited by 95
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer
Alemohammad, H., Najafzadeh, B., Asadzadeh, Z., Baghbanzadeh, A., Ghorbaninezhad, F., Najafzadeh, A., Safarpour, H., Bernardini, R., Brunetti, O., Sonnessa, M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112516 · Cited by 92
CD24: A Novel Target for Cancer Immunotherapy
Panagiotou, Ε., Syrigos, N. K., Charpidou, A. G., Kotteas, E. A., & Vathiotis, I. A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081235 · Cited by 93
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
Leone, P., Solimando, A. G., Fasano, R., Argentiero, A., Malerba, E., Buonavoglia, A., Lupo, L., Re, V. D., Silvestris, N., & Racanelli, V. (2021) · Vaccines · doi:10.3390/vaccines9050532 · Cited by 88
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
Kotsari, M., Dimopoulou, V., Koskinas, J. S., & Armakolas, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411471 · Cited by 93
Implication of TIGIT+ human memory B cells in immune regulation
Hasan, M. M., Nair, S. S., O’Leary, J. G., Thompson-Snipes, L., Nyarige, V., Wang, J., Park, W. D., Stegall, M. D., Heilman, R. L., Klintmalm, G. B. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21413-y · Cited by 82
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors
Damsky, W., Jilaveanu, L., Turner, N., Perry, C., Zito, C., Tomayko, M., Leventhal, J., Herold, K., Meffre, E., Bosenberg, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0613-1 · Cited by 78
Single-Cell RNA-Seq Analysis Reveals Microenvironmental Infiltration of Plasma Cells and Hepatocytic Prognostic Markers in HCC With Cirrhosis
Zhang, S., Liu, Z., Wu, D., Chen, L., & Xie, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596318 · Cited by 74
Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization
Chen, M., Xiao, C., Lao, X., Yuan, W., Liu, R., Zeng, Q., Wang, J., Ouyang, F., Chen, D., Chan, K., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0329 · Cited by 74
Self-citation
Pathogenic, glycolytic PD-1+ B cells accumulate in the hypoxic RA joint
Floudas, A., Neto, N. G. B., Marzaioli, V., Murray, K., Moran, B., Monaghan, M. G., Low, C., Mullan, R. H., Rao, N. L., Krishna, V., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.139032 · Cited by 73
Risk factors for immune-related adverse events: what have we learned and what lies ahead?
Liu, X., Shi, Y., Zhang, D., Zhou, Q., Liu, J., Chen, M., Xu, Y., Zhao, J., Zhong, W., & Wang, M. (2021) · Biomarker Research · doi:10.1186/s40364-021-00314-8 · Cited by 74
Self-citation
c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses
Wang, X., Wei, Y., Hu, B., Liao, Y., Wan, W., Wan, W., Huang, C.-X., Mahabati, M., Liu, Z., Qu, J.-R., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00948-6 · Cited by 73
Self-citation
Autoimmunity and Cancer—Two Sides of the Same Coin
Sakowska, J., Arcimowicz, Ł., Jankowiak, M., Papak, I., Markiewicz, A., Dziubek, K., Kurkowiak, M., Kote, S., Kaźmierczak-Siedlecka, K., Połom, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.793234 · Cited by 80
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade
Patel, A. J., Willsmore, Z. N., Khan, N., Richter, A. G., Naidu, B. V., Drayson, M. T., Papa, S., Cope, A. P., Karagiannis, S. N., Perucha, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30863-x · Cited by 76
Regulatory B Cells
Wang, L., Fu, Y. L., & Chu, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3532-1_8 · Cited by 78
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences
Chen, S., Huang, C., Liao, G., Sun, H., Xie, Y., Wang, J., He, M., He, M., Dai, Z., Ren, X., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328428 · Cited by 81
Self-citation
Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma
He, M. Y., Peng, A., Huang, X.-Z., Shi, D.-C., Wang, J., Zhao, Q., Lin, H., Kuang, D., Ke, P., & Lao, X. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1219828 · Cited by 71
Self-citation
Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma
Qiu, X., Zhou, T., Li, S., Wu, J., Tang, J., Ma, G., Yang, S., Hu, J., Wang, K., Shen, S., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00824-y · Cited by 74
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
Mirlekar, B., Wang, Y., Li, S., Zhou, M., Entwistle, S., Buysscher, T. D., Morrison, A. B., Herrera, G., Harris, C., Vincent, B. G., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100744 · Cited by 74
Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and PD ‐1high Breg cells
Mao, Y., Wang, Y., Dong, L., Zhang, Q., Wang, C., Zhang, Y., Li, X., & Fu, Z. (2019) · Cancer Science · doi:10.1111/cas.14122 · Cited by 67
Self-citation
Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma
Chen, D., Ning, W.-R., Li, X., Yuan, W., Lao, X., Wang, J., Wu, Y., & Zheng, L. (2018) · Autophagy · doi:10.1080/15548627.2018.1474994 · Cited by 66
Self-citation
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
Ko, A. H., Jordan, A. C., Tooker, E., Lacey, S. F., Chang, R. B., Li, Y., Venook, A. P., Tempero, M. A., Damon, L. E., Fong, L. H., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.017 · Cited by 63
Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma
Elsegood, C. L., Tirnitz‐Parker, J. E. E., Olynyk, J. K., & Yeoh, G. C. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.47 · Cited by 63
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
Sjöberg, E., Frödin, M., Lövrot, J., Mezheyeuski, A., Johansson, M., Harmenberg, U., Egevad, L., Sandström, P., & Östman, A. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0266-8 · Cited by 61
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
Griffin, G. K., Weirather, J. L., Roemer, M. G. M., Lipschitz, M., Kelley, A., Chen, P.-H., Gusenleitner, D., Jeter, E., Pak, C. J., Gjini, E., et al. (2020) · Blood · doi:10.1182/blood.2020006464 · Cited by 61
Toll like receptor 4 and hepatocellular carcinoma; A systematic review
Sepehri, Z., Kiani, Z., Kohan, F., Alavian, S. M., & Ghavami, S. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.04.025 · Cited by 61
Circadian Clock Disruption Suppresses PDL1+ Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer
Liu, J., Wang, C., Cheng, T.-Y., Rixiati, Y., Ji, C., Deng, M., Yao, S., Yuan, L., Zhao, Y., Shen, T., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.02.008 · Cited by 59
Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC
Zhang, Y., Wang, H., & Xiao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095016 · Cited by 57
Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.
Gosalia, A. J., Martin, P. B., & Jones, P. D. (2017) · PubMed Central · Cited by 58
Immunotherapy for hepatocellular carcinoma
Childs, A., Aidoo-Micah, G., Maini, M. K., & Meyer, T. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101130 · Cited by 64
Heterogeneous subsets of B-lineage regulatory cells (Breg cells)
Baba, Y., Saito, Y., & Kotetsu, Y. (2019) · International Immunology · doi:10.1093/intimm/dxz068 · Cited by 63
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
Wu, T., Wu, X., Wang, H., & Chen, L. (2019) · 癌症：英文版 · doi:10.1186/s40880-019-0365-9 · Cited by 55
Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
Lin, Z., Liu, L., Xia, Y., Chen, X., Xiong, Y., Qu, Y., Wang, J., Bai, Q., Guo, J., & Xu, J. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1477461 · Cited by 54
Regulatory B cells in respiratory health and diseases
Menon, M., Hussell, T., & Shuwa, H. A. (2021) · Immunological Reviews · doi:10.1111/imr.12941 · Cited by 58
The Multiple Functions of B Cells in Chronic HBV Infection
Cai, Y., & Yin, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582292 · Cited by 60
Immunosuppressive B cells expressing PD-1/PD-L1 in solid tumors: a mini review
Sun, X., Zhang, T., Li, M., Yin, L., & Xue, J. (2019) · QJM · doi:10.1093/qjmed/hcz162 · Cited by 53
Tumour‐associated B cells in urothelial urinary bladder cancer
Zirakzadeh, A. A., Sherif, A. M., Rosenblatt, R., Bergman, E. A., Winerdal, M., Yang, D., Cederwall, J., Jakobsson, V., Hyllienmark, M., Winqvist, O., et al. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12830 · Cited by 55
The depths of PD-1 function within the tumor microenvironment beyond CD8+ T cells
Laba, S., Mallett, G., & Amarnath, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.022 · Cited by 54
Yin-yang effect of tumor infiltrating B cells in breast cancer: From mechanism to immunotherapy
Zhang, Z., Zhu, Y., Wang, Z., Zhang, T., Wu, P., & Huang, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.008 · Cited by 51
Understanding heterogeneous tumor microenvironment in metastatic melanoma
Yan, Y., Leontovich, A. A., Gerdes, M. J., Desai, K., Dong, J., Sood, A., Santamaría-Pang, A., Mansfield, A. S., Chadwick, C. M., Zhang, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216485 · Cited by 51
Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis
Qin, Y., Peng, F., Ai, L., Mu, S., Li, Y., Yang, C., & Hu, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02004-9 · Cited by 50
Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma
Zhou, L., Liu, R., Wang, Y., Jiao, M., Li, Z., Wang, Z., Huang, C., Shi, G., Ke, A., Wang, L., et al. (2022) · Hepatology · doi:10.1002/hep.32442 · Cited by 52
Self-citation
Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma
Liu, J., Sun, B., Guo, K., Yang, Z., Zhao, Y., Gao, M., Yin, Z., Jiang, K., Dong, C., Gao, Z., et al. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00510-0 · Cited by 50
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker
Akyüz, N., Brandt, A. P., Stein, A., Schliffke, S., Mährle, T., Quidde, J., Goekkurt, E., Loges, S., Haalck, T., Ford, C. T., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30549 · Cited by 50
Regulatory B cells in inflammatory diseases and tumor
Cai, X. T., Zhang, L., & Wei, W. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.007 · Cited by 49
CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis.
He, H., Wu, J., Zang, M., Wang, W., Chang, X., Chen, X., Wang, R., Wu, Z., Wang, L., Wang, D., et al. (2017) · Europe PMC (PubMed Central) · Cited by 48

Authors: Xiao, X., Lao, X.-M., Chen, M.-M., Liu, R.-X., Wei, Y., Ouyang, F.-Z., Chen, D.-P., Zhao, X.-Y., Zhao, Q., Li, X.-F., Liu, C.-L., Zheng, L., & Kuang, D.-M.
Affiliations: 1Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
Sun Yat-sen University Cancer Center (CN)
Sun Yat-sen University (CN)
ORCID: Lao, Xiang-Ming
Chen, Dong-Ping
Zhao, Qiyi
Zheng, Limin
Kuang, Dong-Ming
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2016-05-01
Volume: 6
Issue: 5
Pages: 546-559
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-15-1408
OpenAlex: W2295125580
Cited by: 352
References: 46
Citations by year: 2026: 23 · 2025: 42 · 2024: 37 · 2023: 35 · 2022: 46 · 2021: 57 · 2020: 35 · 2019: 34 · 2018: 20 · 2017: 13 · 2016: 10
FWCI: 15.44
Type: journal article
Language: en
Open access: closed
Locations: Cancer Discovery (publishedVersion)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81422036, 31470855, 81171982)
Guangdong Natural Science Funds for Distinguished Young Scholars (S2013050014639)
Doctoral Dissertation of PR China (201230)
Fundamental Research Funds for the Central Universities (15lgjc09)
Topics: Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: regulatory B cells, hepatocellular carcinoma, PD-L1, TLR4, BCL6, IL-10, STAT6, tumor immunosuppression, T cell suppression, B-cell phenotype, cancer immunotherapy
MeSH terms: Animals, Disease Models, Animal, Flow Cytometry, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Neoplasm Staging, Phenotype, Protein Binding, Recurrence, Signal Transduction, Biomarkers, Gene Expression, Immunophenotyping, Cytokines, Lymphocytes, Tumor-Infiltrating, Disease Progression, Cell Line, Tumor, STAT6 Transcription Factor, Mice, Proto-Oncogene Proteins c-bcl-6, Immunomodulation, B-Lymphocytes, Regulatory, B7-H1 Antigen, Programmed Cell Death 1 Receptor, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks